Today's five, straight off the screen: a heart-scan software maker, a clinical trial manager, a lab instrument maker, a steelmaker and a cancer-test developer.
Heartflow turns heart scans into detailed artery maps for doctors, and growing use of its plaque analysis led it to raise its sales forecast. Today's close took its uptrend to a new high after weeks sideways, and we'll watch to see if it holds.
See the Trend →Fortrea runs clinical trials for drugmakers, and new orders keep outpacing finished work as biotech funding recovers. Today's close was its highest in well over a year, on heavier volume than Friday, and the question now is whether buyers stay.
See Today's Close →Waters makes the instruments labs use to test drugs and food, and it is folding in BD's biosciences and diagnostics business. Today's bar won back most of last week's pullback, and we'll watch to see if that recovery holds.
See the Pullback →Ternium makes flat steel for cars and buildings in Latin America, and higher prices in Mexico and Brazil are widening its margins. It touched a new high today, then gave back part of the gain, with TradingView's technical gauge alongside.
Check the Gauge →Freenome develops blood tests that catch cancer early, and Abbott is set to start selling its FDA-approved colon cancer test this fall. It has recovered most of its late-September pullback, and the jury's still out on whether that rebound holds.
See the Pullback →A screened name is a higher probability, not a sure thing.
This newsletter is for informational purposes only and does not constitute financial advice. TradersPro and its contributors are not registered investment advisors. Always conduct your own due diligence before making investment decisions. Past performance is not indicative of future results.
